Biblio Discovery — Demo Discovery Service

427 hasil

Menampilkan 1–20 · 0,09 detik · RSS

Jurnal

Journal of Health Economics and Outcomes Research

Scopus

ISSN 2327-2236 · Columbia Data Analytics, LLC · 427 artikel di indeks

  1. Artikel Jurnal

    Public Health Impact and Cost-Effectiveness of 2-Dose vs 1-Dose Human Papillomavirus Vaccination Regimen in Saudi Arabia

    Abdullah M. Assiri; Carole Mamane; Dzhumber Ugrekhelidze dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background The Saudi Food and Drug Authority recently registered a 9-valent human papillomavirus (HPV) vaccine, which provides broader protection than the existing 4-valent vaccine against genital warts and various cancers. A single-dose protocol vs a 2-dose protocol has been considered as an…

  2. Artikel Jurnal

    Clean Energy and Health Expenditure in an African Setting: A Socioeconomic Analysis of Household Costs and Willingness to Pay

    Davies Adeloye; Wale O. Ogunleye; Boni M. Ale dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Climate vulnerability in sub-Saharan Africa, including Nigeria, has heightened concern about household energy transitions and associated health and economic impacts. Despite clean fuel initiatives, uncertainty remains regarding household expenditure patterns, health expenditures, and…

  3. Artikel Jurnal

    Real-World Health Care Resource Utilization and Economic Burden Among Patients with Idiopathic Pulmonary Fibrosis in Commercially Insured and Medicare Advantage Populations in the United States

    Joseph Yang; Rebecca Fee; Andrea Steffens dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    **Background:** The economic burden associated with idiopathic pulmonary fibrosis (IPF) is not well understood, especially since the approval of antifibrotic medications to treat IPF in 2014. **Objective:** This study assessed healthcare resource utilization (HCRU) and costs for patients with and…

  4. Artikel Jurnal

    Managing High-Risk Root Caries with Silver Diamine Fluoride Application: A Markov Simulation Study

    Young S. Kim; Ji W. Yoo; Maryam Tabrizi dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Dental caries are common oral health conditions among Medicaid beneficiaries. Silver diamine fluoride (SDF) has been applied to manage dental caries. # Objectives To evaluate the cost-effectiveness of SDF application for managing high-risk root caries within the context of Medicaid, a…

  5. Artikel Jurnal

    Modeling the Public Health Impact of Improved Antiretroviral Therapy Restart Patterns Among People with HIV Who Have Discontinued Treatment

    Hansel E. Tookes; Cillian Copeland; Uche Mordi dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Antiretroviral therapy (ART) has become a cornerstone of human immunodeficiency virus (HIV) management. However, a challenge in HIV care and policy is ensuring individuals remain engaged in care and on treatment over time. Discontinuation of ART is common for various reasons, and…

  6. Artikel Jurnal

    Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Healthcare Utilization and Spending for Patients with Multifocal Motor Neuropathy: A US Claims-Based Analysis

    Nikhil Khandelwal; Caroline Geremakis; Faisal Riaz dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Multifocal motor neuropathy (MMN) is a rare, progressive neurological disease characterized by asymmetrical limb weakness. The real-world healthcare burden of MMN is not well established. # Objectives To characterize the epidemiology, diagnostic procedures, treatment patterns…

  7. Artikel Jurnal

    Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy

    Chui-ying Yip; Eric N. Kemadjou; Daisy Stewart dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Duchenne muscular dystrophy (DMD) is a rare, X-linked inherited disorder starting in early childhood, characterized by progressive muscle loss and weakness, causing disability, loss of ambulation, and cardiopulmonary failure. Economic modeling is required to assess cost-effectiveness…

  8. Artikel Jurnal

    Short and Long-Term Outcomes in Kidney Transplant Recipients with Neutropenia or Leukopenia Following CMV Prophylaxis

    Vladimir Turzhitsky; Qinghua Li; Lei Ai dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Neutropenia and leukopenia following kidney transplant are linked to poor transplant outcomes. One factor that can contribute to neutropenia or leukopenia following transplant is the use of valganciclovir as a cytomegalovirus prophylaxis. # Objective This study aimed to evaluate…

  9. Artikel Jurnal

    Peripheral Intravenous Catheters in Hospitalized Surgical Patients: A US Real-World Data Analysis

    Rena Moon; Julie Gayle; Stephanie Pitts dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Limited evidence exists to evaluate the clinical and economic burden of treating hospitalized surgical patients experiencing peripheral intravenous catheter (PIVC)–associated complications. # Objective To estimate the prevalence of PIVC-associated complications and compare the…

  10. Artikel Jurnal

    Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US Population

    Tariku J. Beyene; Vincent J. Willey; Malvika Venkataraman dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Babies born with congenital pulmonary valve disease (CPVD) face a lifetime burden of disease and significant medical expense beginning in their first year of life. # Objectives To assess costs and burden of care in patients with CPVD from birth through age 65. # Methods This…

  11. Artikel Jurnal

    Modeling Financial Insolvency and Income Loss Insurance in Head and Neck Cancer

    Ana V. Araujo; Murray J. Bartho; Garren M. I. Low dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Head and neck cancer (HNC) carries high morbidity, and its treatment can be functionally devastating, impacting a patient's ability to work. While most patients have medical insurance benefits, studies on the impact of HNC on overall household finances have been limited. # Objectives…

  12. Artikel Jurnal

    The Paradox of Life Extension with Traditional Cost-Effectiveness Analysis: A Case Study with Duchenne Muscular Dystrophy

    Lauren Sedita; Alexa Klimchak; Eleanor Perfetto dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Traditional quality-adjusted life-year (QALY)–based cost-effectiveness analyses (CEAs) may inadvertently penalize treatments extending survival in populations with disabilities. Duchenne muscular dystrophy (DMD) is a rare, progressive disease diagnosed during childhood with significant…

  13. Artikel Jurnal

    Antiretroviral Treatment Switch Among Treatment-Experienced People with HIV

    Benjamin Chastek; Uche Mordi; Mary J. Christoph dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background HIV requires lifelong continuous antiretroviral therapy (ART) to prevent morbidity and mortality and to reduce onward transmission. People with HIV (PWH) may switch ART regimens for various clinical and nonclinical reasons. Identifying patterns of ART switching can inform shared…

  14. Artikel Jurnal

    The Fiscal Consequences for the Canadian Government of Efgartigimod in the Treatment of Generalized Myasthenia Gravis

    Ana Teresa Paquete; Mark P. Connolly; Cynthia Qi dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    **Background:** Generalized myasthenia gravis (gMG) severely impacts activities of daily living. Productivity losses and the need for care can impact household finances and consequently government public accounts. This study adopts a governmental perspective framework to assess the fiscal…

  15. Artikel Jurnal

    Cost-Effectiveness of Continuously Diffused Oxygen Therapy Compared with Negative-Pressure Wound Therapy

    Matthew Mercurio; Lawrence A. Lavery; Animesh Agarwal dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Continuous diffusion of oxygen (CDO) to wounds has demonstrated better effectiveness in healing wounds than negative-pressure wound therapy (NPWT). However, there is limited evidence regarding the cost-effectiveness of CDO therapy and its comparison with NPWT. # Objectives The purpose…

  16. Artikel Jurnal

    Trial Interviews to Explore Glycogen Storage Disease Type Ia Patient Experiences Following Gene Therapy

    Diane M. Turner-Bowker; Jessica Butler; Shayna Egan dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Glycogen storage disease type Ia (GSDIa) is a rare, inherited, autosomal recessive deficiency of glucose-6-phosphatase (G6Pase), an enzyme necessary in glycogenolysis and gluconeogenesis. To maintain normal blood glucose levels and ensure survival, individuals living with GSDIa must…

  17. Artikel Jurnal

    Cost-Effectiveness of an Absorbable Antibacterial Envelope for Infection Control in Cardiac Implantable Electronic Device Procedures in Spain

    Tomás Datino; Daniela Afonso; Elana Greaves dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Infections represent the most serious complication associated with cardiac implantable electronic devices (CIEDs). This can result in prolonged hospital stays, high morbidity and mortality, and a significant economic burden for healthcare systems. # Objectives This study aimed to…

    Juga tersedia di: DOAJ

  18. Artikel Jurnal

    Impact of Early Treatment with Pimavanserin on Healthcare Resource Utilization Among Newly Diagnosed Patients with Parkinson’s Disease Psychosis: A Pre-Post Medicare Claims Database Analysis

    Nazia Rashid; Krithika Rajagopalan; Daksha Gopal dkk.

    Journal of Health Economics and Outcomes Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    # Background Pimavanserin is currently the only atypical antipsychotic (AAP) approved by the US Food and Drug Administration for treating hallucinations and delusions in Parkinson’s disease psychosis (PDP). Benefit and efficacy of pimavanserin have been demonstrated through clinical trials…